|
SPATS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.256750E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.417300E-03 |
| Normal-vs-Stage2 |
7.576200E-02 |
| Normal-vs-Stage3 |
4.682400E-02 |
| Normal-vs-Stage4 |
1.950370E-02 |
| Stage1-vs-Stage2 |
5.670400E-01 |
| Stage1-vs-Stage3 |
5.963200E-01 |
| Stage1-vs-Stage4 |
5.464000E-01 |
| Stage2-vs-Stage3 |
9.420400E-01 |
| Stage2-vs-Stage4 |
3.825200E-01 |
| Stage3-vs-Stage4 |
3.923000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.620100E-04 |
| Normal-vs-AfricanAmerican |
3.798800E-01 |
| Normal-vs-Asian |
3.164200E-03 |
| Caucasian-vs-AfricanAmerican |
1.612590E-01 |
| Caucasian-vs-Asian |
1.694560E-01 |
| AfricanAmerican-vs-Asian |
4.029800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.704300E-03 |
| Normal-vs-Female |
3.096300E-03 |
| Male-vs-Female |
9.680200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.830600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.778400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.498550E-03 |
| Normal-vs-Age(81-100Yrs) |
9.989700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.147000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.048400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.576800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.065800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.570600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.648800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.096400E-03 |
| Normal-vs-Grade 2 |
9.942100E-03 |
| Normal-vs-Grade 3 |
1.384280E-02 |
| Normal-vs-Grade 4 |
1.350020E-02 |
| Grade 1-vs-Grade 2 |
1.275760E-01 |
| Grade 1-vs-Grade 3 |
1.476810E-01 |
| Grade 1-vs-Grade 4 |
6.494000E-01 |
| Grade 2-vs-Grade 3 |
8.105000E-01 |
| Grade 2-vs-Grade 4 |
2.448000E-01 |
| Grade 3-vs-Grade 4 |
2.120000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.017100E-04 |
| Normal-vs-ccB subtype |
5.968200E-02 |
| ccA subtype-vs-ccB subtype |
4.531900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.116200E-03 |
| Normal-vs-N1 |
9.858500E-02 |
| N0-vs-N1 |
3.670200E-01 |
|
|
